(Q40352907)

19 September 2017

Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis (English)

1 reference

19 September 2017

0 references

0 references

B A Kallmann

1

1 reference

19 September 2017

S Fackelmann

2

1 reference

19 September 2017

K V Toyka

3

1 reference

19 September 2017

P Rieckmann

4

1 reference

19 September 2017

K Reiners

5

1 reference

19 September 2017

1 February 2006

1 reference

Multiple Sclerosis Journal

19 September 2017

1 reference

19 September 2017

12

1 reference

19 September 2017

1

1 reference

19 September 2017

58-65

1 reference

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

19 September 2017

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Key issues in the diagnosis and treatment of multiple sclerosis. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurol

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Visual and motor evoked potentials in the course of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Evoked potentials in the diagnosis of multiple sclerosis: a follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

Pattern shift visual, brainstem auditory, and short-latency somatosensory evoked potentials in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1244OA

10.1191/135248506MS1244OA

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference